W. Clay Jackson, MD, DipTh

Department of Family Medicine and Department of Psychiatry, University of Tennessee College of Medicine, Memphis, Tennessee

  • 35Articles
  • 154.9KReads1
  • 1999–2023Active
  • 28Collaborators
  • 127Citations2

About

W. Clay Jackson, MD, DipTh, is affiliated with the Department of Family Medicine and Department of Psychiatry at the University of Tennessee College of Medicine in Memphis. From 1999 to 2023, Jackson has authored 35 articles focusing on depression, bipolar disorder, and primary care psychiatry, with particular attention to inadequate antidepressant response, measurement-based care, and patient communication. The work also encompasses topics such as suicide, end-of-life and palliative care, and multiple sclerosis. Frequent collaborators include George I. Papakostas, Madhukar H. Trivedi, and Roueen Rafeyan.

Publications

PCC
Targeted Treatment of Agitation in Alzheimer’s Dementia
Academic Highlights

Targeted Treatment of Agitation in Alzheimer’s Dementia

September 22, 2026

The panelists provide recommendations to give primary care clinicians a practical, evidence-based guide for managing agitation in Alzheimer's dementia, and the confidence to apply it.
, , , et al
PCC
Screening for Bipolar Disorder and Evaluating the RMS
Original Research

Screening for Bipolar Disorder and Evaluating the RMS

April 25, 2023

Health care providers found the Rapid Mood Screener, a new bipolar I disorder screening tool, to be superior to the widely used Mood Disorder Questionnaire in sensitivity/specificity, brevity, practicality,...
, , , et al
JCP
Talking With Patients Who Have Major Depressive Disorder About the Benefits and Risks Associated With Atypical Antipsychotics
Insights

Talking With Patients Who Have Major Depressive Disorder About the Benefits and Risks Associated With Atypical Antipsychotics

April 6, 2021

Learn how to talk with patients who have major depressive disorder about antipsychotic treatment in a way that is clear and balanced and addresses patients’ potential concerns about taking...
, , , et al
JCP
Switching Versus Augmentation in Patients With Inadequate Antidepressant Response
Insights

Switching Versus Augmentation in Patients With Inadequate Antidepressant Response

April 6, 2021

Expert discuss why clinicians often switch antidepressants before considering augmentation strategies, as well as the potential consequences of those treatment decisions
, , , et al
JCP
Residual Symptoms Seen in Patients With Inadequate Antidepressant Response
Insights

Residual Symptoms Seen in Patients With Inadequate Antidepressant Response

April 6, 2021

An expert panel describes residual symptoms often seen in patients with major depressive disorder who have inadequate response to antidepressants
, , , et al
JCP
Benefits of Implementing Measurement-Based Care in Clinical Practice
Insights

Benefits of Implementing Measurement-Based Care in Clinical Practice

April 6, 2021

Dr Roueen Rafeyan relates how implementation of measurement-based care has provided valuable insights into his patients’ clinical status
, , , et al
JCP
Commentary

MDD Treatment: Response to Antidepressants

May 19, 2020

Read commentary on inadequate antidepressant response for MDD. Determining where patients are on the response continuum and managing inadequate response.
, , , et al
JCP
Augmentation and Adjunctive Strategies for Inadequate Response in MDD
Educational Activity

Augmentation and Adjunctive Strategies for Inadequate Response in MDD

May 12, 2020

When a patient with major depressive disorder isn't responding to antidepressant treatment, what are your next moves? In this activity, learn from the experts about augmentation and adjunctive strategies.
, , , et al
JCP
Overcoming Challenges to Treat Inadequate Response in MDD
Educational Activity

Overcoming Challenges to Treat Inadequate Response in MDD

May 12, 2020

How do you determine if a patient is experiencing nonresponse to an antidepressant? In this activity, experts discuss augmentation and adjunctive treatment strategies, as well as best practices for...
, , , et al
JCP
Use of Measurement-Based Care to Address Inadequate Antidepressant Response
Educational Activity

Use of Measurement-Based Care to Address Inadequate Antidepressant Response

May 5, 2020

You may think using rating scales to measure depression symptoms takes too long. But that time may be well spent. In this activity, experts discuss the value of measurement-based...
, , , et al
JCP
Recognizing Inadequate Response in Patients With MDD
Educational Activity

Recognizing Inadequate Response in Patients With MDD

May 5, 2020

Can you recognize inadequate antidepressant response? How does it differ from treatment-resistant depression? In this activity, experts discuss definitions of response as well as residual symptoms seen with inadequate...
, , , et al
JCP
Educational Activity

The Benefits of Measurement-Based Care for Primary Care Patients With Depression

March 23, 2016

1 Read counts for articles published before 2020 may include some non-human traffic.

2 Citation counts provided by Crossref.

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Ketamine and Psychedelics

Listen to the Podcast
The Journal of Clinical Psychiatry podcast cover with Benjamin Brody, MD

Subscribe to read
more articles

Subscribe